It is also known that plasma adiponectin concentration is decreased with ischemic heart disease and obesity and that adiponectin has strong cellular protective properties, acting through the AMPkinase- and cyclooxygenase-2-activated mechanisms [31]. This evidence concerns the gene PTGS2 and obesity disorder.